Skip to main content

Advertisement

Log in

Cannabinoid Neuroimmune Modulation of SIV Disease

  • INVITED REVIEW
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

Marijuana is one of the most commonly used and abused drugs. Δ-9-tetrahydrocannabinol (Δ-9-THC), the primary psychoactive component in marijuana, is FDA-approved to ameliorate AIDS-associated wasting. Because cannabinoid receptors are expressed on cells of the immune system, it is possible that chronic Δ-9-THC use may impact HIV disease progression. Until recently, longitudinal, controlled, systems-approach studies on the effects of cannabinoids on disease progression were lacking. Data from our controlled studies in non-human primates show chronic Δ-9-THC administration prior to and during simian immunodeficiency virus (SIV) infection ameliorates disease progression, attenuates viral load and tissue inflammation, significantly reducing morbidity and mortality of SIV-infected macaques. Identification of possible mechanisms responsible for this modulation of disease progression is complicated due to the multiplicity of cannabinoid-mediated effects, tissue-specific responses to the viral infection, multiple cellular mechanisms involved in inflammatory responses, coordinated neuroendocrine and localized responses to infection, and kinetics of viral replication. Emerging results from our studies reveal that the overall mechanisms mediating the protective effects of cannabinoids involve novel epigenomic regulatory mechanisms in need of systematic investigation. Here, we review the evidence supporting an immunomodulatory role for cannabinoids and its impact on disease progression with focus on HIV/SIV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M (2003) Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med 139:258–266

    PubMed  CAS  Google Scholar 

  • Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315–348

    Article  PubMed  CAS  Google Scholar 

  • Arthur LO, Gilden RV, Marx PA, Gardner MB (1986) Simian acquired immunodeficiency syndrome. Prog Allergy 37:332–352

    PubMed  CAS  Google Scholar 

  • Bell JE, Brettle RP, Chiswick A, Simmonds P (1998) HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121(Pt 11):2043–2052

    Article  PubMed  Google Scholar 

  • Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M (2001) Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatr 58:721–728

    Article  PubMed  CAS  Google Scholar 

  • Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P (1996) Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem 237:704–711

    Article  PubMed  CAS  Google Scholar 

  • Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI (2002) Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. J Clin Pharmacol 42:82S–89S

    PubMed  CAS  Google Scholar 

  • Breitling R, Armengaud P, Amtmann A, Herzyk P (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573:83–92

    Article  PubMed  CAS  Google Scholar 

  • Brown TT, Dobs AS (2002) Endocrine effects of marijuana. J Clin Pharmacol 42:90S–96S

    PubMed  CAS  Google Scholar 

  • Cabral GA, Griffin-Thomas L (2008) Cannabinoids as therapeutic agents for ablating neuroinflammatory disease. Endocr Metab Immune Disord Drug Targets 8:159–172

    Article  PubMed  CAS  Google Scholar 

  • Cabral GA, Stinnett AL, Bailey J, Ali SF, Paule MG, Scallet AC, Slikker W Jr (1991) Chronic marijuana smoke alters alveolar macrophage morphology and protein expression. Pharmacol Biochem Behav 40:643–649

    Article  PubMed  CAS  Google Scholar 

  • Chao C, Jacobson LP, Tashkin D, Martinez-Maza O, Roth MD, Margolick JB, Chmiel JS, Rinaldo C, Zhang ZF, Detels R (2008) Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men. Drug Alcohol Depend 94:165–171

    Article  PubMed  Google Scholar 

  • Connolly NC, Riddler SA, Rinaldo CR (2005) Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches. AIDS Rev 7:168–180

    PubMed  Google Scholar 

  • Covic M, Hassa PO, Saccani S, Buerki C, Meier NI, Lombardi C, Imhof R, Bedford MT, Natoli G, Hottiger MO (2005) Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J 24:85–96

    Article  PubMed  CAS  Google Scholar 

  • Daul CB, Heath RG (1975) The effect of chronic marihuana usage on the immunological status of rheusus monkeys. Life Sci 17:875–881

    Article  PubMed  CAS  Google Scholar 

  • Decrion AZ, Dichamp I, Varin A, Herbein G (2005) HIV and inflammation. Curr HIV Res 3:243–259

    Article  PubMed  CAS  Google Scholar 

  • Dewey WL (1986) Cannabinoid pharmacology. Pharmacol Rev 38:151–178

    PubMed  CAS  Google Scholar 

  • Di Franco MJ, Sheppard HW, Hunter DJ, Tosteson TD, Ascher MS (1996) The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men’s Health Study. Ann Epidemiol 6:283–289

    Article  PubMed  Google Scholar 

  • Donahoe RM, O’neil SP, Marsteller FA, Novembre FJ, Anderson DC, Lankford-Turner P, McClure HH (2009) Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque/SIVsmm9 model. J Acquir Immune Defic Syndr 50:241–249

    Article  PubMed  Google Scholar 

  • Ehrhart J, Obregon D, Mori T, Hou H, Sun N, Bai Y, Klein T, Fernandez F, Tan J, Shytle RD (2005) Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation 2:29

    Article  PubMed  Google Scholar 

  • ElSohly MA, deWit H, Wachtel SR, Feng S, Murphy TP (2001) Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study. J Anal Toxicol 25:565–571

    PubMed  CAS  Google Scholar 

  • Faubert Kaplan BL, Kaminski NE (2003) Cannabinoids inhibit the activation of ERK MAPK in PMA/Io-stimulated mouse splenocytes. Int Immunopharmacol 3:1503–1510

    Article  PubMed  CAS  Google Scholar 

  • Felder CC, Glass M (1998) Cannabinoid receptors and their endogenous agonists. Annu Rev Pharmacol Toxicol 38:179–200

    Article  PubMed  CAS  Google Scholar 

  • Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW (1996) Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393:231–235

    Article  PubMed  CAS  Google Scholar 

  • Fischer-Stenger K, Dove Pettit DA, Cabral GA (1993) Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events. J Pharmacol Exp Ther 267:1558–1565

    PubMed  CAS  Google Scholar 

  • Friedman H, Klein TW, Newton C, Daaka Y (1995) Marijuana, receptors and immunomodulation. Adv Exp Med Biol 373:103–113

    Article  PubMed  CAS  Google Scholar 

  • Friedman H, Newton C, Klein TW (2003) Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 16:209–219

    Article  PubMed  CAS  Google Scholar 

  • Galvan FH, Burnam MA, Bing EG (2003) Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. J Psychoactive Drugs 35(Suppl 1):153–160

    Article  PubMed  Google Scholar 

  • Gardner MB, Luciw PA (1988) Simian immunodeficiency viruses and their relationship to the human immunodeficiency viruses. AIDS 2(Suppl 1):S3–10

    Article  PubMed  Google Scholar 

  • Groot F, van Capel TM, Schuitemaker J, Berkhout B, de Jong EC (2006) Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission. Retrovirology 3:52

    Article  PubMed  Google Scholar 

  • Gumbi PP, Nkwanyana NN, Bere A, Burgers WA, Gray CM, Williamson AL, Hoffman M, Coetzee D, Denny L, Passmore JA (2008) Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection. J Virol 82:8529–8536

    Article  PubMed  CAS  Google Scholar 

  • Hollister LE (1986) Health aspects of cannabis. Pharmacol Rev 38:1–20

    PubMed  CAS  Google Scholar 

  • Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607–634

    Article  PubMed  CAS  Google Scholar 

  • Hurtrel B, Chakrabarti L, Hurtrel M, Maire MA, Dormont D, Montagnier L (1991) Early SIV encephalopathy. J Med Primatol 20:159–166

    PubMed  CAS  Google Scholar 

  • Kfutwah AK, Mary JY, Nicola MA, Blaise-Boisseau S, Barre-Sinoussi F, Ayouba A, Menu E (2006) Tumour necrosis factor-alpha stimulates HIV-1 replication in single-cycle infection of human term placental villi fragments in a time, viral dose and envelope dependent manner. Retrovirology 3:36

    Article  PubMed  Google Scholar 

  • Khalsa JH, Royal W (2004) Do drugs of abuse impact on HIV disease? J Neuroimmunol 147:6–8

    Article  PubMed  CAS  Google Scholar 

  • Kino T, Mirani M, Alesci S, Chrousos GP (2003) AIDS-related lipodystrophy/insulin resistance syndrome. Horm Metab Res 35:129–136

    Article  PubMed  CAS  Google Scholar 

  • Klein TW, Lane B, Newton CA, Friedman H (2000) The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 225:1–8

    Article  PubMed  CAS  Google Scholar 

  • Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H (2003) The cannabinoid system and immune modulation. J Leukoc Biol 74:486–496

    Article  PubMed  CAS  Google Scholar 

  • Kotler DP, Reka S, Clayton F (1993) Intestinal mucosal inflammation associated with human immunodeficiency virus infection. Dig Dis Sci 38:1119–1127

    Article  PubMed  CAS  Google Scholar 

  • Kumar R, Torres C, Yamamura Y, Rodriguez I, Martinez M, Staprans S, Donahoe RM, Kraiselburd E, Stephens EB, Kumar A (2004) Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol 78:11425–11428

    Article  PubMed  CAS  Google Scholar 

  • LeCapitaine NJ, Zhang P, Winsauer P, Walker E, Vande Stouwe C, Porretta C, Molina PE (2011) Chronic Delta-9-tetrahydrocannabinol Administration Increases Lymphocyte CXCR4 Expression in Rhesus Macaques. J Neuroimmune Pharmacol

  • Lee LM, Karon JM, Selik R, Neal JJ, Fleming PL (2001) Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984–1997. JAMA 285:1308–1315

    Article  PubMed  CAS  Google Scholar 

  • Li Q, Duan L, Estes JD, Ma ZM, Rourke T, Wang Y, Reilly C, Carlis J, Miller CJ, Haase AT (2005) Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434:1148–1152

    PubMed  CAS  Google Scholar 

  • Lu TS, Avraham HK, Seng S, Tachado SD, Koziel H, Makriyannis A, Avraham S (2008) Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J Immunol 181:6406–6416

    PubMed  CAS  Google Scholar 

  • Lu TX, Munitz A, Rothenberg ME (2009) MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 182:4994–5002

    Article  PubMed  CAS  Google Scholar 

  • Mannioui A, Bourry O, Sellier P, Delache B, Brochard P, Andrieu T, Vaslin B, Karlsson I, Roques P, Le Grand R (2009) Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques. Retrovirology 6:106

    Article  PubMed  Google Scholar 

  • McGowan I, Elliott J, Fuerst M, Taing P, Boscardin J, Poles M, Anton P (2004) Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J Acquir Immune Defic Syndr 37:1228–1236

    Article  PubMed  CAS  Google Scholar 

  • Substance Abuse and Mental Health Services Administration (2004) Overview of Findings from the 2003 National Survey on Drug Use and Health Office of Applied Studies, NSDUH Series H-24 DHHS Publication No. SMA 04–3963

  • Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, Miedema F (1992) Programmed death of T cells in HIV-1 infection. Science 257:217–219

    Article  PubMed  CAS  Google Scholar 

  • Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD (1998) Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 279:1223–1227

    Article  PubMed  CAS  Google Scholar 

  • Molina PE (2005) Neurobiology of the stress response: contribution of the sympathetic nervous system to the neuroimmune axis in traumatic injury. Shock 24:3–10

    Article  PubMed  CAS  Google Scholar 

  • Molina PE (2006) Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness. J Intern Med 259:138–154

    Article  PubMed  CAS  Google Scholar 

  • Molina PE, Winsauer P, Zhang P, Walker E, Birke L, Amedee A, Stouwe CV, Troxclair D, McGoey R, Varner K, Byerley L, Lamotte L (2010) Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus. AIDS Res Hum Retrovir 27(6):585–592

    Article  PubMed  Google Scholar 

  • Moschos SA, Williams AE, Perry MM, Birrell MA, Belvisi MG, Lindsay MA (2007) Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics 8:240

    Article  PubMed  Google Scholar 

  • Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–65

    Article  PubMed  CAS  Google Scholar 

  • Murphy R, Wente SR (1996) An RNA-export mediator with an essential nuclear export signal. Nature 383:357–360

    Article  PubMed  CAS  Google Scholar 

  • Nahas GG, Suciu-Foca N, Armand JP, Morishima A (1974) Inhibition of cellular mediated immunity in marihuana smokers. Science 183:419–420

    Article  PubMed  CAS  Google Scholar 

  • Nair MP, Mahajan S, Hewitt R, Whitney ZR, Schwartz SA (2004) Association of drug abuse with inhibition of HIV-1 immune responses: studies with long-term of HIV-1 non-progressors. J Neuroimmunol 147:21–25

    Article  PubMed  CAS  Google Scholar 

  • Newton CA, Klein TW, Friedman H (1994) Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun 62:4015–4020

    PubMed  CAS  Google Scholar 

  • Noe SN, Nyland SB, Ugen K, Friedman H, Klein TW (1998) Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN. Adv Exp Med Biol 437:223–229

    Article  PubMed  CAS  Google Scholar 

  • Pandrea IV, Gautam R, Ribeiro RM, Brenchley JM, Butler IF, Pattison M, Rasmussen T, Marx PA, Silvestri G, Lackner AA, Perelson AS, Douek DC, Veazey RS, Apetrei C (2007) Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J Immunol 179:3035–3046

    PubMed  CAS  Google Scholar 

  • Paradisi A, Pasquariello N, Barcaroli D, Maccarrone M (2008) Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J Biol Chem 283:6005–6012

    Article  PubMed  CAS  Google Scholar 

  • Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129–180

    Article  PubMed  CAS  Google Scholar 

  • Pertwee RG, Stevenson LA, Griffin G (1993) Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. Br J Pharmacol 110:1483–1490

    PubMed  CAS  Google Scholar 

  • Peterson PK, Gekker G, Hu S, Cabral G, Lokensgard JR (2004) Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures. J Neuroimmunol 147:123–126

    Article  PubMed  CAS  Google Scholar 

  • Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM (2004) Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr 35:38–45

    Article  PubMed  Google Scholar 

  • Pross SH, Klein TW, Newton CA, Smith J, Widen R, Friedman H (1990) Differential suppression of T-cell subpopulations by thc (delta-9-tetrahydrocannabinol). Int J Immunopharmacol 12:539–544

    Article  PubMed  CAS  Google Scholar 

  • Raborn ES, Cabral GA (2010) Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor. J Pharmacol Exp Ther 333:319–327

    Article  PubMed  CAS  Google Scholar 

  • Reiss CS (2010) Cannabinoids and Viral Infections. Pharmaceuticals (Basel) 3:1873–1886

    CAS  Google Scholar 

  • Rock RB, Gekker G, Hu S, Sheng WS, Cabral GA, Martin BR, Peterson PK (2007) WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. J Neuroimmune Pharmacol 2:178–183

    Article  PubMed  Google Scholar 

  • Romagnani S, Del Prete G, Manetti R, Ravina A, Annunziato F, De Carli M, Mazzetti M, Piccinni MP, D’Elios MM, Parronchi P (1994) Role of TH1/TH2 cytokines in HIV infection. Immunol Rev 140:73–92

    Article  PubMed  CAS  Google Scholar 

  • Roth MD, Tashkin DP, Whittaker KM, Choi R, Baldwin GC (2005) Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse. Life Sci 77:1711–1722

    Article  PubMed  CAS  Google Scholar 

  • Sabri N, Roth P, Xylourgidis N, Sadeghifar F, Adler J, Samakovlis C (2007) Distinct functions of the Drosophila Nup153 and Nup214 FG domains in nuclear protein transport. J Cell Biol 178:557–565

    Article  PubMed  CAS  Google Scholar 

  • Sankaran S, George MD, Reay E, Guadalupe M, Flamm J, Prindiville T, Dandekar S (2008) Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 82:538–545

    Article  PubMed  CAS  Google Scholar 

  • Thuru X, Chamaillard M, Karsak M, Gantier E, Erdual E, Dubuquoy C, Phillipe D, Rousseaux C, Wang YC, Dubus P, Stalewski J, Menzaghi F, Schteingart C, Zimmer A, Riviere P, Desreumaus P (2007) Cannabinoid receptor 2 is required for homeostatic control of intestinal inflammation. Gastroenterology 132:A228

    Google Scholar 

  • Verhoeven D, Sankaran S, Silvey M, Dandekar S (2008) Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells. J Virol 82:4016–4027

    Article  PubMed  CAS  Google Scholar 

  • Watson SJ, Benson JA Jr, Joy JE (2000) Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report. Arch Gen Psychiatr 57:547–552

    Article  PubMed  CAS  Google Scholar 

  • Winsauer PJ, Molina PE, Amedee AM, Filipeanu CM, McGoey RR, Troxclair DA, Walker EM, Birke LL, Stouwe CV, Howard JM, Leonard ST, Moerschbaecher JM, Lewis PB (2011) Tolerance to chronic delta-9-tetrahydrocannabinol (Delta-THC) in rhesus macaques infected with simian immunodeficiency virus. Exp Clin Psychopharmacol 19:154–172

    Article  PubMed  CAS  Google Scholar 

  • Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N (2007) miRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2:e1020

    Article  PubMed  Google Scholar 

  • Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH (2008) MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 135:1624–1635.e24

    Article  PubMed  CAS  Google Scholar 

  • Yuan M, Kiertscher SM, Cheng Q, Zoumalan R, Tashkin DP, Roth MD (2002) Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol 133:124–131

    Article  PubMed  CAS  Google Scholar 

  • Zhang C (2008) MicroRNomics: a newly emerging approach for disease biology. Physiol Genom 33:139–147

    Article  Google Scholar 

  • Zhang R, Mehla R, Chauhan A (2010) Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus −1 preintegration complex (DNA). PLoS One 5:e15620

    Article  PubMed  CAS  Google Scholar 

  • Zhu W, Friedman H, Klein TW (1998) Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J Pharmacol Exp Ther 286:1103–1109

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank all of the individuals that have provided technical and analytical support (Jaime Hubbell, Tesslyn Land, Edith Walker, Blake Lewis, Nedra Lacour), as well as critical scientific discussions with Drs. Joe Moerschbaecher, Robert Siggins, Leslie Birke, Robin McGoey, and Lisa Harrison-Bernard. The authors are indebted to Dr. Marilyn Huestis from NIDA Intramural Research Program for THC analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricia E. Molina.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Molina, P.E., Amedee, A., LeCapitaine, N.J. et al. Cannabinoid Neuroimmune Modulation of SIV Disease. J Neuroimmune Pharmacol 6, 516–527 (2011). https://doi.org/10.1007/s11481-011-9301-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-011-9301-8

Keywords

Navigation